Common use of IRO Transactions Review Clause in Contracts

IRO Transactions Review. The Transactions Review shall consist of a review and assessment of whether Good Days has complied with the PAP Measures outlined in Section III.F of the IA. For the first Reporting Period, the IRO shall review four of the active disease funds operated by Good Days during calendar year 2020. (Active disease funds are those which provided financial assistance to patients during the applicable Reporting Period.) Two of the four funds reviewed shall be funds with a single donor. Those single-donor funds shall be randomly selected by the IRO from among the ten Good Days single-donor funds that provided assistance to the largest number of patients in 2020. The remaining two funds reviewed for calendar year 2020 shall be randomly selected by the IRO from the active disease funds with multiple donors. For the second and third Reporting Periods, the IRO shall review four, or ten percent, of the active disease funds operated by Good Days, whichever is a larger number. OIG shall have the discretion to select the types of funds to be reviewed by the IRO, and the number of each fund type reviewed (up to a total of four or 10% of the active disease funds), and shall do so based on information provided by Good Days and other information known to OIG. No later than November 1 of each calendar year beginning in 2020, Good Days shall submit to OIG information about the number of active disease funds operated by Good Days, which of those funds are single-donor funds, and other information requested by OIG. For purposes of the Transactions Review, the term “Reviewed Materials” shall include, for each disease fund reviewed, the records specifically referenced in Section III.F of the IA and other documents sufficient to allow the IRO to review and assess whether Good Days complied with each element of the PAP Measures outlined in Section III.F. In addition, the IRO may interview Good Days personnel regarding Good Days’ policies and practices relating to Patient Assistance Related Functions.‌‌

IRO Transactions Review. ‌ The Transactions Review shall consist of a review and assessment of whether Good Days TAF has complied with the PAP Measures outlined in Section III.F of the IA. For the first Reporting Period, the IRO shall review four six of the active disease funds operated by Good Days TAF during calendar year 2020. (Active disease funds are those which provided financial assistance to patients during the applicable Reporting Period.) Two Four of the four six funds reviewed shall be funds with a single donor. Those single-donor funds shall be randomly selected by the IRO from among the ten Good Days TAF single-donor funds that provided assistance to the largest number of patients in 2020. The remaining two funds reviewed for calendar year 2020 shall be randomly selected by the IRO from the active disease funds with multiple donors. For the second and third Reporting Periods, the IRO shall review foursix, or ten percent, of the active disease funds operated by Good DaysTAF, whichever is a larger number. OIG shall have the discretion to select the types of funds to be reviewed by the IRO, and the number of each fund type reviewed (up to a total of four six or 10% of the active disease funds), and shall do so based on information provided by Good Days TAF and other information known to OIG. No later than November 1 of each calendar year beginning in 2020, Good Days TAF shall submit to OIG information about the number of active disease funds operated by Good DaysTAF, which of those funds are single-donor funds, and other information requested by OIG. For purposes of the Transactions Review, the term “Reviewed Materials” shall include, for each disease fund reviewed, the records specifically referenced in Section III.F of the IA and other documents sufficient to allow the IRO to review and assess whether Good Days TAF complied with each element of the PAP Measures outlined in Section III.F. In addition, the IRO may interview Good Days TAF personnel regarding Good Days’ TAF’s policies and practices relating to Patient Assistance Related Functions.‌‌